WEDNESDAY 8 JUNE 2016 MEETING
HEPATITIS C AND DRUG USE IN GREECE 2016 PROGRAM
Î&#x;rganization:
Supported by:
HEPATITIS C AND DRUG USE IN GREECE 2016
TIME 9:00 - 9:15 9:15 - 9:30
SPEAKER
TITLE
Welcome
Α. Ksanthos
Minister of Health
National Hepatitis C Action Plan
International Goals and Strategies for Hepatitis C and Drug Use
Chairs: M. Malliori - Professor of Psychiatry, University of Athens (EKPA), 1st Psychiatric Clinic - Aiginiteio Hospital D. Kountouras - Doctor - Hepatologist, Member of Board of Hellenic Center for Disease Control and Prevention (HCDCP) 9:30 - 9:50
I. Hodges Mameletzis
HIV Department at World Health Organization
WHO Global Ηealth Sector Strategy on Viral Hepatitis
L. Maistat
9:50 - 10:10
10:10 - 10:30
Senior Programme Manager Hepatitis/HIV Policy and Advocacy, Internationa HIV/AIDS Alliance
Th. Apostolou
Director of Association Diogenis, Drug Policy Dialogue
Treatment and Harm Reduction in Ukraine Special Session About Drugs of the UN General Assembly (UNGASS 2016): Inauguration of a substantial shift in drug policy? Questions
10:30 - 10:40
Hepatitis C Treatment Chairs: G. N. Ntalekos - Chair of Board, Hellenic Association for the Study of the Liver E.Tsiroyianni - Pathologist, 4th Opioid Substitution Treatment Unit (OST), OKANA
G. Papathedoridis
10:40 - 11:00
11:00 - 11:20
11:20 - 11:40
Professor of Medicine - Gastroenterology, University of Athens and Director of the Gastroenterology University Clinic, Laiko Gen. Hospital
New Therapies for Hepatitis C: Efficacy Estimates from Clinical Trials & Clinical Practice
N. Dedes
Diagnosis without Treatment: An ethical dilemma
S. Mpersimis
The plans of the National Organization for the Provision of Healthcare Services (OPYY) for Treating Hepatitis C
Chair of Board, “Positive Voice” Association
Chair of Board of the Greek National Organization for Healthcare Services Provision (EOPYY)
11:40 - 11:50
Questions
11:50 - 12:30
Coffee break
Wednesday 8 of June 2016
TIME
SPEAKER
TITLE
Hepatitis C and Drug Use in Greece: Data, Actions and Strategies
Chairs: G. Touloumi - Professor, Dept. of Hygiene, Epidemiology and Medical Statistics School of Medicine, University of Athens E. Kakalou - Doctor - Infectious Diseases Specialist and University of Athens 12:10 - 12:30
Μ. Deutsch
Assistant Professor of Medicine - Hepatology, Ippokratio Gen. Hospital
V. Sypsa
12:30 - 12:50
Data on Drug Use and Hepatitis C in Europe and Greece The Impact of Expanding Antiviral Treatment and Harm Reduction Programmes in the Epidemic of Hepatitis C Among PWID in Greece
Assistant Professor of Epidemiology and Preventive Medicine Dept. of Hygiene, Epidemiology and Medical Statistics School of Medicine, University of Athens
V. Gkitakos
Programs of KETHEA EKSELIKSIS & PROMETHEUS in Athens & Thessaloniki
E. Kafetzopoulos
The Plans of OKANA for Achieving the Goals of W.H.O for Hepatitis C
12:50 - 13:10
Director of KETHEA Therapy Centre for Dependent Individuals
13:10 - 13:30
Chair of Board of the Greek Organization Against Drugs - OKANA
13:30 - 13:40
Questions
13:40 - 14:00
Coffee break HCV Treatment in People Who Inject Drugs (PWID): Barriers and Concerns Chairs: M. Kloka - Advocacy Officer for NGO Praksis F. Leobilla - MSc Sociologist - Social Therapist
14:00 - 14:20
O. Anagnostou
Pathologist, Opioid Substitution Treatment Unit (OST), Organization Against Drugs-OKANA
Management of People Who Inject Drugs with Hepatitis C
M. Atzemis
14:20 - 14:40
Member of Harm Reduction Actions, “Positive Voice”,
Ε. Kokkini
Chair og Board of Greek Substitute and Users Union, OKANA
Living with Hepatitis C though the Perspective of Civil Society
14:40 - 15:00
Questions
15:00 - 15:30
Discussion: Under which Conditions it is Possible to Achieve the Goals of WHO for Hepatitis C Among PWID in Greece? Chairs: G. Kalamitsis - Chair of Board of Hellenic Liver Patient Association “Prometheus” A. Hatzakis - Professor Dept. of Hygiene, Epidemiology and Medical Statistics School of Medicine, University of Athens
Light Lunch
Sponsored by: